BSECompany Update22 Aug 2026 · 22 Aug 2026, 04:32 pm

Announcement under SEBI Listing Regulations regarding Schedule of Institutional Investor Meet.

Global Health Ltd · 543654

✦ AI SummaryRegulatory

Global Health Ltd has announced an institutional investor meet, scheduled for August 26 and 27, 2026, where the company's management will meet with investors and analysts. The meeting will be held in physical mode, and no unpublished price-sensitive information will be shared.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk3/10
Liquidity Impact6/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Attachments (1)

📄

737cfac4-eb13-4e64-b88c-56205c4cd12c.pdf

pdf

Download →
View document text
Date: August 22, 2026 Ref:- GHL/2026-27/EXCH/47 The General Manager The Manager Dept. of Corporate Services Listing Department BSE Limited, National Stock Exchange of India Limited P J Towers, Dalal Street, Exchange Plaza, C-1, Block G, Mumbai - 400 001 Bandra Kurla Complex, Bandra (E), Mumbai - 400 051 Scrip Code: 543654 Symbol: MEDANTA Sub: Intimation for Schedule of Analyst/Institutional Investor Meeting. Dear Sir(s), Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Company’s Management will meet Investor/Analyst in Meeting organised as per the below schedule: Name Date of Meeting Type of Meeting Mode of Meeting Motilal Oswal Financial Services August 26,2026 one to one Physical Limited Motilal Oswal Financial Services August 27,2026 one to one Physical Limited Please note that, no Unpublished Price Sensitive Information is proposed to be shared, thereat. Note: Please note that the above meeting is subject to change in case of any unforeseen circumstances, on the part of Analysts/Investors/Company. Kindly take the above on record. For Global Health Limited Rahul Ranjan Company Secretary & Compliance Officer M. No. A17035 Regd. Office: E-18, Defence Colony, New Delhi 110024, Ph No.011- 44114411 www.medanta.org, info@medanta.org, CIN: L85110DL2004PLC128319